Clinical Trials Directory

Trials / No Longer Available

No Longer AvailableNCT03723096

Expanded Access for CC-4047

Status
No Longer Available
Phase
—
Study type
Expanded Access
Enrollment
—
Sponsor
Celgene · Industry
Sex
All
Age
—
Healthy volunteers
—

Summary

This is an expanded access program (EAP) for eligible participants designed to provide access to CC-4047.

Conditions

Interventions

TypeNameDescription
DRUGCC-4047CC-4047 will be administered orally

Timeline

First posted
2018-10-29
Last updated
2018-12-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03723096. Inclusion in this directory is not an endorsement.

Expanded Access for CC-4047 (NCT03723096) · Clinical Trials Directory